Ocular medicines in children: the regulatory situation related to clinical research
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2431
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Ocular medicines in children: the regulatory situation related to clinical research ; volume:12 ; number:1 ; day:20 ; month:1 ; year:2012 ; pages:1-13 ; date:12.2012
BMC pediatrics ; 12, Heft 1 (20.1.2012), 1-13, 12.2012
- Creator
-
Fortinguerra, Filomena
- Contributor
-
Clavenna, Antonio
Bonati, Maurizio
SpringerLink (Online service)
- DOI
-
10.1186/1471-2431-12-8
- URN
-
urn:nbn:de:1111-2016081315013
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fortinguerra, Filomena
- Clavenna, Antonio
- Bonati, Maurizio
- SpringerLink (Online service)
Other Objects (12)
Is Medicines Parallel Trade "Regulatory Arbitrage'"?
Is medicines parallel trade ‘regulatory arbitrage’?
Regulatory roadmap for nanotechnology based medicines
Regulatory Reform Outcomes and Accelerated Regulatory Pathways for New Prescription Medicines in Australia
Requirements for generic anti-epileptic medicines: a regulatory perspective
Penetrating Eyelid and Ocular Fishhook-Related Injury
Establishment of the African Medicines Agency: progress, challenges and regulatory readiness
International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines
Ocular manifestations of transthyretin-related familial amyloid polyneuropathy
Correction: International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines
Network medicines™
Epimax-Related Ocular Surface Toxicity (EROST): the Glasgow experience
Is Medicines Parallel Trade "Regulatory Arbitrage'"?
Is medicines parallel trade ‘regulatory arbitrage’?
Regulatory roadmap for nanotechnology based medicines
Regulatory Reform Outcomes and Accelerated Regulatory Pathways for New Prescription Medicines in Australia
Requirements for generic anti-epileptic medicines: a regulatory perspective
Penetrating Eyelid and Ocular Fishhook-Related Injury
Establishment of the African Medicines Agency: progress, challenges and regulatory readiness
International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines
Ocular manifestations of transthyretin-related familial amyloid polyneuropathy
Correction: International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines
Network medicines™
Epimax-Related Ocular Surface Toxicity (EROST): the Glasgow experience
Is Medicines Parallel Trade "Regulatory Arbitrage'"?
Is medicines parallel trade ‘regulatory arbitrage’?
Regulatory roadmap for nanotechnology based medicines
Regulatory Reform Outcomes and Accelerated Regulatory Pathways for New Prescription Medicines in Australia
Requirements for generic anti-epileptic medicines: a regulatory perspective
Penetrating Eyelid and Ocular Fishhook-Related Injury
Establishment of the African Medicines Agency: progress, challenges and regulatory readiness
International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines
Ocular manifestations of transthyretin-related familial amyloid polyneuropathy
Correction: International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines
Network medicines™